Hematopoietic Stem Cell Transplantation

Displaying 51 - 66 of 66CSV
Etra, A., Gergoudis, S., Morales, G., Spyrou, N., Shah, J., Kowalyk, S., Ayuk, F., Baez, J., Chanswangphuwana, C., Chen, Y.-B., Choe, H., DeFilipp, Z., Gandhi, I., Hexner, E., Hogan, W. J., Holler, E., Kapoor, U., Kitko, C. L., Kraus, S., … Levine, J. E. (2022). Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification. Blood Advances, 6(12), 3707–3715. https://doi.org/10.1182/bloodadvances.2022007296
Publication Date
Chakraborty, R., Siddiqi, R., Willson, G., Gupta, S., Asghar, N., Husnain, M., Aljama, M. A., Behera, T. R., Anwer, F., Perrot, A., & Riaz, I. B. (2022). Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high‐risk cytogenetics: A meta‐analysis of randomized controlled trials. Cancer, 128(12), 2288–2297. Portico. https://doi.org/10.1002/cncr.34211
Publication Date
LaBere, B., Gutierrez, M. J., Wright, H., Garabedian, E., Ochs, H. D., Fuleihan, R. L., Secord, E., Marsh, R., Sullivan, K. E., Cunningham-Rundles, C., Notarangelo, L. D., & Chen, K. (2022). Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry. The Journal of Allergy and Clinical Immunology: In Practice, 10(5), 1325-1333.e5. https://doi.org/10.1016/j.jaip.2021.12.035
Publication Date
Nauman, G., Danzl, N. M., Lee, J., Borsotti, C., Madley, R., Fu, J., Hölzl, M. A., Dahmani, A., Dorronsoro Gonzalez, A., Chavez, É., Campbell, S. R., Yang, S., Satwani, P., Liu, K., & Sykes, M. (2022). Defects in Long-Term APC Repopulation Ability of Adult Human Bone Marrow Hematopoietic Stem Cells (HSCs) Compared with Fetal Liver HSCs. The Journal of Immunology, 208(7), 1652–1663. https://doi.org/10.4049/jimmunol.2100966
Publication Date
Bansal, R., Park, H., Taborda, C. C., Gordillo, C., Mapara, M. Y., Assal, A., Uhlemann, A.-C., & Reshef, R. (2022). Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 28(3), 135–144. https://doi.org/10.1016/j.jtct.2021.12.015
Publication Date
Kanter, J., Walters, M. C., Krishnamurti, L., Mapara, M. Y., Kwiatkowski, J. L., Rifkin-Zenenberg, S., Aygun, B., Kasow, K. A., Pierciey, F. J., Bonner, M., Miller, A., Zhang, X., Lynch, J., Kim, D., Ribeil, J.-A., Asmal, M., Goyal, S., Thompson, A. A., & Tisdale, J. F. (2022). Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. New England Journal of Medicine, 386(7), 617–628. https://doi.org/10.1056/nejmoa2117175
Publication Date
Menghrajani, K., Gomez-Arteaga, A., Madero-Marroquin, R., Zhang, M.-J., Bo-Subait, K., Sanchez, J., Wang, H.-L., Aljurf, M., Assal, A., Bacher, V. U., Badawy, S. M., Bejanyan, N., Bhatt, V. R., Bredeson, C., Byrne, M., Castillo, P., Cerny, J., Chhabra, S., Ciurea, S. O., … Saber, W. (2022). Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Advances, 6(3), 828–847. https://doi.org/10.1182/bloodadvances.2021004881
Publication Date
Sidana, S., Kumar, S., Fraser, R., Estrada-Merly, N., Giralt, S., Agrawal, V., Anderson, L. D., Aljurf, M., Banerjee, R., Bashey, A., Battiwalla, M., Beitinjaneh, A., Chakraborty, R., Chhabra, S., Dhakal, B., Dholaria, B., Hashmi, S., Janakiram, M., Lee, C., … D’Souza, A. (2022). Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation. Transplantation and Cellular Therapy, 28(2), 83.e1-83.e9. https://doi.org/10.1016/j.jtct.2021.10.022
Publication Date
Zou, J., Wang, T., He, M., Bolon, Y.-T., Gadalla, S. M., Marsh, S. G. E., Kuxhausen, M., Gale, R. P., Sharma, A., Assal, A., Prestidge, T., Aljurf, M., Cerny, J., Paczesny, S., Spellman, S. R., Lee, S. J., & Ciurea, S. O. (2022). Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study. Transplantation and Cellular Therapy, 28(2), 107.e1-107.e8. https://doi.org/10.1016/j.jtct.2021.11.001
Publication Date
Macedo, R., Pasin, C., Ganetsky, A., Harle, D., Wang, X. K., Belay, K., Richman, L. P., Huffman, A. P., Vonderheide, R. H., Yates, A. J., Porter, D. L., Wang, Y., Zhang, Y., & Reshef, R. (2022). Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signature. Transplantation and Cellular Therapy, 28(1), 18.e1-18.e10. https://doi.org/10.1016/j.jtct.2021.09.017
Publication Date
Eisler, L., Chihuri, S., Lenke, L. G., Sun, L. S., Faraoni, D., & Li, G. (2021). Development of a preoperative risk score predicting allogeneic red blood cell transfusion in children undergoing spinal fusion. Transfusion, 62(1), 100–115. Portico. https://doi.org/10.1111/trf.16722
Publication Date
Pasvolsky, O., Yeshurun, M., Fraser, R., Estrada-Merly, N., Rozovski, U., Shargian-Alon, L., Assal, A., Banerjee, R., Bumma, N., Gale, R. P., Hagen, P., Holmberg, L., Hossain, N. M., Lazarus, H. M., Lee, C., Mian, H., Miller, K. C., Nathan, S., Nagler, A., … D’Souza, A. (2021). Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. Bone Marrow Transplantation, 57(1), 31–37. https://doi.org/10.1038/s41409-021-01455-y
Publication Date
Jimenez Jimenez, A. M., De Lima, M., Komanduri, K. V., Wang, T. P., Zhang, M.-J., Chen, K., Abdel-Azim, H., Abid, M. B., Aljurf, M., Alkhateeb, H., Assal, A., Bacher, U., Baron, F., Battiwalla, M., Beitinjaneh, A., Bejanyan, N., Bhatt, V. R., Byrne, M., Cahn, J.-Y., … Weisdorf, D. (2021). An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. Bone Marrow Transplantation, 56(12), 3068–3077. https://doi.org/10.1038/s41409-021-01450-3
Publication Date
Herrera, A. F., Ahn, K. W., Litovich, C., Chen, Y., Assal, A., Bashir, Q., Bayer, R.-L., Coleman, M., DeFilipp, Z., Farhadfar, N., Greenwood, M., Hahn, T., Horwitz, M., Jacobson, C., Jaglowski, S., Lachance, S., Langston, A., Mattar, B., Maziarz, R. T., … Hamadani, M. (2021). Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome. Blood Advances, 5(18), 3528–3539. https://doi.org/10.1182/bloodadvances.2021004865
Publication Date
Lisco, A., Hsu, A. P., Dimitrova, D., Proctor, D. M., Mace, E. M., Ye, P., Anderson, M. V., Hicks, S. N., Grivas, C., Hammoud, D. A., Manion, M., Starrett, G. J., Farrel, A., Dobbs, K., Brownell, I., Buck, C., Notarangelo, L. D., Orange, J. S., Leonard, W. J., … Sereti, I. (2021). Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer Cells. New England Journal of Medicine, 385(10), 921–929. https://doi.org/10.1056/nejmoa2102715
Publication Date